Share Price | Mahamaya Lifesciences Ltd Stock Analysis & Recommendation

Q: Why is Mahamaya Lifesciences Ltd falling/rising?

As of 11-Jun, Mahamaya Lifesciences Ltd's stock price is falling, currently at 175.65, which reflects a decrease of 4.15 or 2.31%. This decline follows a trend reversal after five consecutive days of gains. The stock opened today with a significant loss of 3.73% and reached an intraday low of Rs 170.1, marking a drop of 5.39%. Additionally, the stock has underperformed its sector by 0.44% today.Investor participation has also decreased, with delivery volume falling by 68.75% compared to the five-day average, indicating reduced interest from investors. Despite trading above its moving averages for 5, 20, 50, 100, and 200 days, the overall performance in the past week shows a gain of 13.32% against a slight decline in the benchmark Sensex, which fell by 0.71%. However, the stock's performance over the past month and year-to-date remains negative, with declines of 2.06% and 4.80%, respectively. These factors contribute to the current downward movement in Mahamaya Lifesciences Ltd's stock price.

Q: How big is Mahamaya Lifesc.?

As of 10th June, Market Cap: Mahamaya Lifesciences Ltd has a market capitalization of 414.00 Cr, categorizing it as a Micro Cap company.Recent Quarterly Performance: There is no valid financial data available for the latest four quarters regarding Net Sales and Net Profit.Balance Sheet Snapshot: The latest reporting period is March 2025, with Shareholder's Funds amounting to 49.42 Cr and Total Assets valued at 188.35 Cr.

Q: Who are the peers of the Mahamaya Lifesc.?

Peers: The peers of Mahamaya Lifesc. are Punjab Chemicals, Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, Bhaskar Agrochem, Crop Life Scienc, Aristo Bio-Tech, and Dhansa Labs.Quality Snapshot: Excellent management risk is observed at Dharmaj Crop and Bhaskar Agrochem, while Good management risk is found at Best Agrolife. Average management risk is present at Punjab Chemicals, Heranba Inds, Crop Life Scienc, Aristo Bio-Tech, and the rest. Below Average management risk is noted at Shivalik Rasayan and Dhansa Labs. Growth is classified as Excellent for Dharmaj Crop, Good for Bhaskar Agrochem and Best Agrolife, Average for Aristo Bio-Tech, and Below Average for Punjab Chemicals, Heranba Inds, Crop Life Scienc, Shivalik Rasayan, and Dhansa Labs. Capital Structure is rated as Excellent for Dharmaj Crop and Shivalik Rasayan, Good for Punjab Chemicals and Bhaskar Agrochem, Average for Heranba Inds, Best Agrolife, and Aristo Bio-Tech, and Below Average for Crop Life Scienc and Dhansa Labs.Return Snapshot: The peer with the highest 1-year return is Bhaskar Agrochem at 28.03%, while the lowest is Heranba Inds at -32.49%. Mahamaya Lifesc.'s 1-year return is not available for comparison. Additionally, the peers with negative six-month returns include Heranba Inds, Best Agrolife, Shivalik Rasayan, and Dhansa Labs.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

19.2 k (-25.93%) Volume

Shareholding (Mar 2026)

FII

4.77%

Held by 4 FIIs

DII

2.52%

Held by 0 DIIs

Promoter

56.35%

Why is Mahamaya Lifesciences Ltd falling/rising?

12-Jun-2026

As of 11-Jun, Mahamaya Lifesciences Ltd's stock price is at 175.65, down 2.31% after a trend reversal following five days of gains. Investor interest has decreased significantly, and despite a recent weekly gain, the stock has underperformed over the past month and year-to-date.

View full answer

Which are the latest news on Mahamaya Lifesc.?

12-Jun-2026

When is the next results date for Mahamaya Lifesciences Ltd?

How big is Mahamaya Lifesc.?

11-Jun-2026

As of 10th June, Mahamaya Lifesciences Ltd has a market capitalization of 414.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for the latest four quarters regarding Net Sales and Net Profit.

View full answer

Who are the peers of the Mahamaya Lifesc.?

11-Jun-2026

Mahamaya Lifesc.'s peers include Punjab Chemicals, Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, Bhaskar Agrochem, Crop Life Science, Aristo Bio-Tech, and Dhansa Labs. Key performance metrics show varying management risks, growth rates, and capital structures among these companies, with Bhaskar Agrochem achieving the highest 1-year return at 28.03% and Heranba Inds the lowest at -32.49%.

View full answer

When is the next results date for Mahamaya Lifesciences Ltd?

21-May-2026

The next results date for Mahamaya Lifesciences Ltd is 25 May 2026.

View full answer

Compare Mahamaya Lifesc. with Similar Stocks

Best Agrolife Shivalik Rasayan Advance Agrolife

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pesticides & Agrochemicals

Market cap

INR 405 Cr (Micro Cap)

P/E

25.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.42

Return on Equity

13.63%

Price to Book

3.43

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

9.78%

6 Months

27.28%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Mahamaya Lifesc. for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Mahamaya Lifesciences Ltd?

The next results date for Mahamaya Lifesciences Ltd is scheduled for 25 May 2026....

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Press Release / Media Release

26-May-2026 | Source : BSE

Submission of Press Release on Audited Financial Results for FY26

The Audited (Standalone & Consolidated) Financial Results Of The Company For The Half Year And Financial Year Ended 31.03.2026 Along With The Audit Reports Thereon

25-May-2026 | Source : BSE

Audited Financial Results (Standalone & Consolidated) of the Company for the half year and financial year ended 31.03.2026 along with the Audit Reports thereon.

Board Meeting Outcome for Audited Financial Results (Standalone & Consolidated) For The Half Year And Year Ended On 31.03.2026

25-May-2026 | Source : BSE

Audited Financial Results along with Auditors Report for the half year and financial Year ended on 31st March 2026

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

3.07

Debt to EBITDA (avg)

2.69

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.54

Tax Ratio

30.54%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

7.30%

ROCE (avg)

18.08%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.36

EV to EBIT

14.73

EV to EBITDA

13.75

EV to Capital Employed

2.66

EV to Sales

1.41

PEG Ratio

Dividend Yield

ROCE (Latest)

18.08%

ROE (Latest)

13.63%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Bullish

KST

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (4.77%)

Promoter with highest holding

Krishnamurthy Ganesan (21.86%)

Highest Public shareholder

Pink Tiger Alliances Llp (10.35%)

Individual Investors Holdings

10.65%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 1.54% vs 11.69% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is -2.63% vs 15.45% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "165.90",
          "val2": "163.39",
          "chgp": "1.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.38",
          "val2": "15.43",
          "chgp": "12.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.29",
          "val2": "3.85",
          "chgp": "11.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.15",
          "val2": "8.37",
          "chgp": "-2.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.48%",
          "val2": "9.46%",
          "chgp": "1.02%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 23.91% vs 64.48% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 28.96% vs 145.40% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "329.28",
          "val2": "265.75",
          "chgp": "23.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "33.51",
          "val2": "24.41",
          "chgp": "37.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.14",
          "val2": "6.81",
          "chgp": "19.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.52",
          "val2": "12.81",
          "chgp": "28.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.19%",
          "val2": "9.24%",
          "chgp": "0.95%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Consolidated) - Mar'26

Mar'26

Sep'25

Change(%)

Net Sales

165.90

163.39

1.54%

Operating Profit (PBDIT) excl Other Income

17.38

15.43

12.64%

Interest

4.29

3.85

11.43%

Exceptional Items

0.00

Consolidate Net Profit

8.15

8.37

-2.63%

Operating Profit Margin (Excl OI)

10.48%

9.46%

1.02%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Mar 2026 is 1.54% vs 11.69% in Sep 2025

Consolidated Net Profit

Growth in half year ended Mar 2026 is -2.63% vs 15.45% in Sep 2025

All Half Yearly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

329.28

265.75

23.91%

Operating Profit (PBDIT) excl Other Income

33.51

24.41

37.28%

Interest

8.14

6.81

19.53%

Exceptional Items

0.00

Consolidate Net Profit

16.52

12.81

28.96%

Operating Profit Margin (Excl OI)

10.19%

9.24%

0.95%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 23.91% vs 64.48% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 28.96% vs 145.40% in Mar 2025

All Annual Results

Company CV

About Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Ltd

Micro Cap

Pesticides & Agrochemicals

Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as "Mahamaya Life Sciences Private Limited" by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002. Further, Company's name was changed from "Mahamaya Life Sciences Private Limited" to "Mahamaya Lifesciences Private Limited" dated February 15, 2016. The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre.

Company Coordinates

No Company Details Available